Ganesh Gunasekaran, Yuki Bekki, Vennis Lourdusamy, Myron Schwartz – 21 May 2020 – Hepatobiliary cancers which include hepatocellular carcinoma (HCC) and biliary tract cancers (i.e., cholangiocarcinoma and gallbladder carcinoma) are associated with significant morbidity and mortality based on the stage of the disease at presentation. With improved screening for hepatobiliary malignancies in patients with risk factors and with widespread use of laparoscopic cholecystectomy, hepatobiliary malignancies, including incidental diagnosis of gallbladder carcinoma, are on the rise.

George Lau, John W. Ward – 21 May 2020

K. Rajender Reddy – 21 May 2020

Matthew R. Kappus, Kara Wegermann, Erol Bozdogan, Yuval A. Patel, Gemini Janas, Erin Shropshire, Alice Parish, Donna Niedzwiecki, Andrew J. Muir, Mustafa Bashir – 20 May 2020 – The aim of this study is to validate a proposed definition of sarcopenia in predicting wait‐list mortality. We retrospectively evaluated 355 adults (age ≥18 years) with cirrhosis listed for first‐time LT from January 1, 2010, to April 1, 2018 from our center. Demographic, laboratory, and outcome data were collected in conjunction with computed tomography scans performed within 3 months of listing.

Josep M. Llovet, Augusto Villanueva, Jorge A. Marrero, Myron Schwartz, Tim Meyer, Peter R. Galle, Riccardo Lencioni, Tim F. Greten, Masatoshi Kudo, Sumithra J. Mandrekar, Andrew X. Zhu, Richard S. Finn, Lewis R. Roberts, AASLD Panel of Experts on Trial Design in HCC – 20 May 2020

Extrahepatic manifestations of HCV contribute to its increased overall mortality rate in those infected relative to those who aren’t; associated cardiovascular, neoplastic and renal manifestations can contribute significantly to a patient’s truncated lifespan beyond liver-related morbidity. This webinar will address the recognition and the treatment of extrahepatic manifestations of chronic HCV infection. We will utilize a live webinar format that will be recorded for on-demand viewing on Liver Learning ® .Miklos Z. Molnar Dr. Miklos Z.

Torsten J. Selck, Julia Bök, Ramona Amintavakoli – 19 May 2020

Lorenzo De Marchi, Cindy J. Wang, Nikolaos J. Skubas, Rishi Kothari, Jeron Zerillo, Kathirvel Subramaniam, Guy E. Efune, Michelle Y.C. Braunfeld, Susan Mandel – 19 May 2020 – More anesthesiologists are routinely using transesophageal echocardiography (TEE) during liver transplant surgery, but the effects on patient outcome are unknown. Transplant anesthesiologists are therefore uncertain if they should undergo additional training and adopt TEE.

Manuela Cesaretti, Raffaele Brustia, Claire Goumard, François Cauchy, Nicolas Poté, Federica Dondero, Catherine Paugam‐Burtz, François Durand, Valerie Paradis, Alberto Diaspro, Leonardo Mattos, Olivier Scatton, Olivier Soubrane, Sara Moccia – 19 May 2020 – The worldwide implementation of a liver graft pool using marginal livers (ie, grafts with a high risk of technical complications and impaired function or with a risk of transmitting infection or malignancy to the recipient) has led to a growing interest in developing methods for accurate evaluation of graft quality.

Pegah Golabi, James M. Paik, Tamoore Arshad, Youssef Younossi, Alita Mishra, Zobair M. Younossi – 19 May 2020 – Although nonalcoholic fatty liver disease (NAFLD) is associated with obesity, it can also occur in lean and metabolically normal individuals. Our aim was to determine the effect of different combinations of abdominal adiposity and overall adiposity on the mortality of NAFLD. The Third National Health and Nutrition Examination Survey with mortality data from the National Death Index were used. NAFLD was defined as steatosis without other liver diseases.